Multispecies Outbreak of Verona Integron-Encoded Metallo-ß-Lactamase-Producing Multidrug Resistant Bacteria Driven by a Promiscuous Incompatibility Group A/C2 Plasmid.
Enterobacteriaceae
carbapenemase
hospital-acquired infection
plasmid
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
01 02 2021
01 02 2021
Historique:
received:
12
08
2019
accepted:
17
01
2020
pubmed:
8
4
2020
medline:
29
4
2021
entrez:
8
4
2020
Statut:
ppublish
Résumé
Antibiotic resistance is often spread through bacterial populations via conjugative plasmids. However, plasmid transfer is not well recognized in clinical settings because of technical limitations, and health care-associated infections are usually caused by clonal transmission of a single pathogen. In 2015, multiple species of carbapenem-resistant Enterobacteriaceae (CRE), all producing a rare carbapenemase, were identified among patients in an intensive care unit. This observation suggested a large, previously unrecognized plasmid transmission chain and prompted our investigation. Electronic medical record reviews, infection control observations, and environmental sampling completed the epidemiologic outbreak investigation. A laboratory analysis, conducted on patient and environmental isolates, included long-read whole-genome sequencing to fully elucidate plasmid DNA structures. Bioinformatics analyses were applied to infer plasmid transmission chains and results were subsequently confirmed using plasmid conjugation experiments. We identified 14 Verona integron-encoded metallo-ß-lactamase (VIM)-producing CRE in 12 patients, and 1 additional isolate was obtained from a patient room sink drain. Whole-genome sequencing identified the horizontal transfer of blaVIM-1, a rare carbapenem resistance mechanism in the United States, via a promiscuous incompatibility group A/C2 plasmid that spread among 5 bacterial species isolated from patients and the environment. This investigation represents the largest known outbreak of VIM-producing CRE in the United States to date, which comprises numerous bacterial species and strains. We present evidence of in-hospital plasmid transmission, as well as environmental contamination. Our findings demonstrate the potential for 2 types of hospital-acquired infection outbreaks: those due to clonal expansion and those due to the spread of conjugative plasmids encoding antibiotic resistance across species.
Sections du résumé
BACKGROUND
Antibiotic resistance is often spread through bacterial populations via conjugative plasmids. However, plasmid transfer is not well recognized in clinical settings because of technical limitations, and health care-associated infections are usually caused by clonal transmission of a single pathogen. In 2015, multiple species of carbapenem-resistant Enterobacteriaceae (CRE), all producing a rare carbapenemase, were identified among patients in an intensive care unit. This observation suggested a large, previously unrecognized plasmid transmission chain and prompted our investigation.
METHODS
Electronic medical record reviews, infection control observations, and environmental sampling completed the epidemiologic outbreak investigation. A laboratory analysis, conducted on patient and environmental isolates, included long-read whole-genome sequencing to fully elucidate plasmid DNA structures. Bioinformatics analyses were applied to infer plasmid transmission chains and results were subsequently confirmed using plasmid conjugation experiments.
RESULTS
We identified 14 Verona integron-encoded metallo-ß-lactamase (VIM)-producing CRE in 12 patients, and 1 additional isolate was obtained from a patient room sink drain. Whole-genome sequencing identified the horizontal transfer of blaVIM-1, a rare carbapenem resistance mechanism in the United States, via a promiscuous incompatibility group A/C2 plasmid that spread among 5 bacterial species isolated from patients and the environment.
CONCLUSIONS
This investigation represents the largest known outbreak of VIM-producing CRE in the United States to date, which comprises numerous bacterial species and strains. We present evidence of in-hospital plasmid transmission, as well as environmental contamination. Our findings demonstrate the potential for 2 types of hospital-acquired infection outbreaks: those due to clonal expansion and those due to the spread of conjugative plasmids encoding antibiotic resistance across species.
Identifiants
pubmed: 32255490
pii: 5817041
doi: 10.1093/cid/ciaa049
pmc: PMC10327870
mid: NIHMS1913216
doi:
Substances chimiques
Anti-Bacterial Agents
0
Bacterial Proteins
0
beta-Lactamases
EC 3.5.2.6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
414-420Subventions
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : ErratumIn
Informations de copyright
© Published by Oxford University Press for the Infectious Diseases Society of America 2020.
Références
Front Microbiol. 2017 Feb 09;8:182
pubmed: 28232822
Am J Infect Control. 2015 Jun;43(6):635-9
pubmed: 25868648
Int J Med Microbiol. 2013 Aug;303(6-7):298-304
pubmed: 23499304
MMWR Morb Mortal Wkly Rep. 2010 Sep 24;59(37):1212
pubmed: 20864922
Microbiol Spectr. 2014 Oct 10;2(5):0012
pubmed: 25392747
Antimicrob Agents Chemother. 2000 Apr;44(4):891-7
pubmed: 10722487
Antimicrob Agents Chemother. 2010 Oct;54(10):4497-502
pubmed: 20660690
JAMA. 2014 Oct 8;312(14):1447-55
pubmed: 25291580
Front Microbiol. 2017 Mar 13;8:375
pubmed: 28348549
MMWR Morb Mortal Wkly Rep. 2016 Feb 26;65(7):190
pubmed: 26914726
Int J Antimicrob Agents. 2016 Feb;47(2):158-62
pubmed: 26795022
Nat Methods. 2013 Jun;10(6):563-9
pubmed: 23644548
Vet Microbiol. 2017 Feb;200:114-117
pubmed: 26411323
Clin Infect Dis. 2015 Aug 15;61(4):593-600
pubmed: 25904368
J Clin Microbiol. 2016 Mar;54(3):791-4
pubmed: 26719440
J Antimicrob Chemother. 2016 Nov;71(11):3117-3124
pubmed: 27494919
Clin Infect Dis. 2018 Jul 2;67(2):171-178
pubmed: 29409044
Sci Transl Med. 2014 Sep 17;6(254):254ra126
pubmed: 25232178
Clin Microbiol Rev. 2015 Jul;28(3):565-91
pubmed: 25926236
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
Science. 2018 Mar 2;359(6379):
pubmed: 29371424
mSphere. 2016 Jan 13;1(1):
pubmed: 27303709
Antimicrob Agents Chemother. 2012 Feb;56(2):783-6
pubmed: 22123704
J Antimicrob Chemother. 2016 Nov;71(11):3081-3089
pubmed: 27494913
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
J Antimicrob Chemother. 2017 Sep 1;72(9):2410-2417
pubmed: 28637307
Infect Control Hosp Epidemiol. 2016 Dec;37(12):1426-1432
pubmed: 27619507
Am J Med. 2006 Jun;119(6 Suppl 1):S20-8; discussion S62-70
pubmed: 16735147
Plasmid. 2015 Jul;80:63-82
pubmed: 25910948
Antimicrob Agents Chemother. 2016 May 23;60(6):3767-78
pubmed: 27067320
Clin Infect Dis. 2011 Jul 1;53(1):60-7
pubmed: 21653305
Antimicrob Agents Chemother. 1999 Jul;43(7):1584-90
pubmed: 10390207
Emerg Infect Dis. 2013 Jun;19(6):870-8
pubmed: 23731823
Antimicrob Agents Chemother. 2009 Dec;53(12):5046-54
pubmed: 19770275
Trends Genet. 2010 Aug;26(8):335-40
pubmed: 20598393